ALKYLAMIDO COMPOUNDS AND USES THEREOF
    6.
    发明授权
    ALKYLAMIDO COMPOUNDS AND USES THEREOF 有权
    ALKYLAMIDO-VERBINDUNGEN UND IHRE VERWENDUNGEN

    公开(公告)号:EP2396081B1

    公开(公告)日:2017-04-05

    申请号:EP10708105.1

    申请日:2010-02-16

    摘要: Disclosed herein are compounds of formula (I) that may be specific to PPAR and/or EGF receptors, and methods of making and using same. wherein X is C 1 -C 3 alkylene, optionally substituted with one, two or three substituents selected from halogen or hydroxyl; R 1 is selected from the group consisting of C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 2 -C 6 alkenyl, and C 2 -C 6 alkynyl; R 2 is selected from the group consisting of hydrogen and C 1 -C 6 alkyl; R 3 is independently selected, for each occurrence from the group consisting of hydrogen, C 1 -C 6 alkoxy, C 1 -C 6 alkyl, cyano, C 3 -C 6 cycloalkyl, halogen, hydroxyl, and nitro; R 4 is selected from the group consisting of hydrogen and C 1 -C 6 alkyl; R 5 is hydrogen C 1 -C 6 alkyl; or pharmaceutically acceptable salts or N-oxides thereof.

    摘要翻译: 本文公开了可以对PPAR和/或EGF受体特异的式(I)化合物及其制备和使用方法。 其中X是任选被1,2或3个选自卤素或羟基的取代基取代的C 1 -C 3亚烷基; R 1选自C 1 -C 6烷基,C 3 -C 6环烷基,C 2 -C 6烯基和C 2 -C 6炔基; R 2选自氢和C 1 -C 6烷基; R 3各自独立地选自氢,C 1 -C 6烷氧基,C 1 -C 6烷基,氰基,C 3 -C 6环烷基,卤素,羟基和硝基; R 4选自氢和C 1 -C 6烷基; R 5是氢C 1 -C 6烷基; 或其药学上可接受的盐或N-氧化物。